Assembly Biosciences
Anthony Altig is the current Director at Assembly Biosciences. Anthony has over 20 years of experience as a Chief Financial Officer, including at Biotix Holdings, Diversa, and Maxim Pharmaceuticals. Anthony also has experience as a Board of Director, including at Optimer Pharmaceuticals, and as a Chief Accounting Officer at USWeb/CKS. Prior to their career in finance, they worked as a Manager at KPMG Peat Marwick.
Anthony Altig has a BBA in Business from the University of Hawaii at Manoa. Anthony also attended McDaid School.
This person is not in the org chart
This person is not in any offices
Assembly Biosciences
9 followers
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets.